Escape velocity out of a small base: management describes the business compounding at a rate its own size cannot absorb
The model's full reasoning — Q4 2016 call → NOWe need to determine if management describes the company as being at a point where the rate of accumulation has become the dominant fact, with multiples and repeated doublings, and treating the base as still small. Let's analyze the transcript. Key points from management: - John Higgins: "Last year was a year distinguished by solid financial performance, significant increased investment in R&D, excellent integration of our OMT acquisition at the start of last year and substantial expansion of our portfolio of fully funded programs." He mentions "stellar royalty growth" and "major contributions from contract payments." He says "corporate gross margins were 95% for 2016 and the company generated significant cash flow from operations." - He discusses Promacta revenues: "Q4 Promacta revenues by Novartis were $178 million and full-year 2016 revenues were $635 million. That is an impressive 37% growth over full year 2015 revenue." That's a percentage growth, not a multiple. - Kyprolis: "Amgen reported $183 million in Q4 Kyprolis sales which result in full-year sales of $692 million." No multiple. - Evomela: "It was approved and launched in 2016, so last year was the first year Ligand earned royalties." No multiple. - He mentions "record high revenue" and "record high quarterly numbers" but not multiples. - Matt Foehr: talks about Captisol sample requests: "In 2016 we processed over 820 new inbound Captisol sample requests which is a record high. As a comparison in 2011 when we bought Captisol and brought it into Ligand we received less than 200 inbound requests." That's a multiple: 820 vs less than 200, so about 4 times. But is that a "real and already banked" activity? Yes, sample requests are actual activity. But is it a dominant fact? He also mentions "over 450 research use and animal use agreements" but no multiple there. - He also says "Interest in Captisol continues to grow substantially." But the multiple is just one example. - Matt Korenberg: "2016 was another year of significant growth for Ligand with respect to revenue, royalties and cash flow." He mentions "total revenues for the quarter were $38.2 million and included royalty revenue of $19.6 million. Both of these figures represent record high quarterly numbers for Ligand since the transition to our current business model 10 years ago." Record high, not multiple.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| SNOW | Snowflake Inc. | Q3 2022 | 2021-12-01 | A |
SNOW · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Frank Slootman repeatedly frames the current state in terms of multiples of the recent past: product revenue “growing 110% year-on-year” (more than doubling), EMEA “up 174%” and Asia-Pacific “219%”, BUILD Summit registrations “three times last year’s”, Snow Day “ 23,000 registrations”, Data Marketplace “grew 41%”, stable edges “more than 130% annual increase”, Powered By Snowflake partners “growing 137% quarter-on-quarter” and product revenue from them “173% year-on-year”.
DASH · Q3 2023 → YESThe question is whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as still sm...YES The transcript shows management repeatedly framing the business in terms of multiples of its recent past: non-restaurant selection "going from 0 nearly 3 years ago to a multibillion-dollar business that's at scale now growing fast"; grocery GOV "has doubled year-on-year"; international growth "at multiples of what we see around the world"; and new verticals accelerating from the prior quarter.
SYM · Q3 2022 → YESThe question is about whether management describes the company as accumulating at a rate that's the dominant fact, using multiples or repeated doublings of its recent past, and treating the base as st...YES Management repeatedly frames the current state using multiples of recent past activity: backlog more than doubled (from $5.2B to $11.